BMC Medical Co (301367) Fair Value & Analysis

Healthcare · CN · Market cap 5.2B CNY

Analysis

BMC Medical Co (301367) currently trades at ¥40.95, while our model-based Fair Value estimate is ¥39.63 — implying the stock looks roughly 3.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well as PAP devices and CPAP masks. The company also provides snoring, sleep apnea, asthma, and chronic obstructive pulmonary disease solutions. BMC Medical Co., Ltd. was founded in 2001 and is based in Beijing, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.